This study aims to evaluate the current trend of male stress urinary incontinence (SUI) management of the Australian population in the 21st century, through Medicare data.

Data was extracted from the Australian Institute of Health and Welfare national morbidity database and Medicare Benefits Schedule (MBS) statistics report. Information was collected as yearly data from financial years (FY) 2000/01 to 2022/23. MBS Procedures for male SUI include retropubic, paraurethral injection and artificial urinary sphincter (AUS). The data consist of procedure counts, differentiated by gender, age, and revisions. The national and state financial burden are calculated from MBS data.

Between FY2000/01 to 2022/23, the total number of procedures related to male SUI increased by 272.2%. The popular procedures being AUS insertion and retropubic procedures. We have also noted an increase in revision procedures performed, with a 444% increase. Male SUI procedures are commonly performed between 65-74 years old and this was true for revision procedures as well. The national cost for services related to male SUI increased by 555.7%. Among the states, NSW contributed the most and among procedures AUS accounted for the largest portion.

In the last two decades of the Australian population, we observed an increase in procedures for male SUI, particularly with retropubic and AUS insertion. In the same period, there is also an increase in revision procedures performed and mostly observed with AUS revision or replacement. The national aggregate cost for male SUI has increased substantially and among the states - NSW contributed the most to this cost.